Extent and Impact of Inadequate Disease Control in US Adults with a History of Moderate to Severe Atopic Dermatitis Following Introduction of New Treatments.

Vilsbøll, Andreas Westh; Anderson, Peter; Piercy, James; Milligan, Gary; Kragh, Nana

Vilsbøll, Andreas Westh; Anderson, Peter; Piercy, James; Milligan, Gary; Kragh, Nana.

Afiliação

Vilsbøll AW; LEO Pharma A/S, Ballerup, Denmark. BWVDK@leo-pharma.com.
Anderson P; Adelphi Real World, Bollington, UK.
Piercy J; Adelphi Real World, Bollington, UK.
Milligan G; Adelphi Real World, Bollington, UK.
Kragh N; LEO Pharma A/S, Ballerup, Denmark.

Dermatol Ther (Heidelb) ; 11(2): 475-486, 2021 Apr.

Article em En | MEDLINE | ID: mdl-33496957

Palavras-chave

Atopic dermatitis; Burden; Disease control; Patient-reported outcomes; Quality of life

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Dermatol Ther (Heidelb) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Dinamarca

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google